Rheumatoid arthritis
Conditions
Interventions
None listed
Sponsors
Saitama Medical Center, Saitama Medical University Department of Rheumatology and Clinical Immunology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: People who had informed consent to this study
Exclusion criteria
Exclusion criteria: People who did not have informed consent to this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change of TCR-z expression on PBMC after treatment with calcineurin inhibitors in SLE patients | — |
Secondary
| Measure | Time frame |
|---|---|
| Association between TCR-z expression and clinical signs and symptoms | — |
Countries
Japan
Contacts
Public ContactTsuneo Kondo
Saitama Medical Center, Saitama Medical Universitity Department of Rheumatology & Clinical Immunology
Outcome results
None listed